Your browser doesn't support javascript.
loading
Long-term survival of renal transplantation in patients with lupus nephritis: experience from a single university centre.
Martínez-López, David; Sánchez-Bilbao, Lara; De Cos-Gómez, Marina; González-Mazón, Iñigo; Rodrigo-Calabia, Emilio; Ruiz-San Millán, Juan Carlos; Gómez Román, Javier; Castañeda, Santos; González-Gay, Miguel Angel; Hernández, Jose Luis; Blanco, Ricardo.
Afiliación
  • Martínez-López D; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology, and Internal Medicine Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Sánchez-Bilbao L; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology, and Internal Medicine Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • De Cos-Gómez M; Nephrology Division, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • González-Mazón I; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology, and Internal Medicine Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Rodrigo-Calabia E; Nephrology Division, Hospital Universitario Marqués de Valdecilla, Santander, and University of Cantabria, School of Medicine, Santander, Spain.
  • Ruiz-San Millán JC; Nephrology Division, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Gómez Román J; Pathology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Castañeda S; Rheumatology Department, Hospital Universitario de la Princesa, IIS-Princesa, Cátedra UAM-Roche (EPID-Future), Universidad Autónoma de Madrid, Spain.
  • González-Gay MA; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology and Internal Medicine Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, and University of Cantabria, School of Medicine, Santander, Spain; and Cardiovascular Pathophysio
  • Hernández JL; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology and Internal Medicine Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, and University of Cantabria, School of Medicine, Santander, Spain. hernandezjluis@gmail.com.
  • Blanco R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology and Internal Medicine Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, and University of Cantabria, School of Medicine, Santander, Spain. rblanco@humv.es.
Clin Exp Rheumatol ; 40(3): 581-588, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34665698
ABSTRACT

OBJECTIVES:

Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE). Unfortunately, 10-20% of patients with LN develop end-stage renal disease (ESRD), and renal transplantation may be a therapeutic option. However, concerns about LN recurrence after transplant have been reported. We aimed to assess long-term post-transplant graft and patient survival in LN compared to patients with non-autoimmune nephropathy (polycystic kidney disease - PCKD).

METHODS:

We carried out a single-centre retrospective study of all patients who underwent renal transplantation due to LN in a referral unit between 1980 and 2018. This cohort was compared with a group of PCKD patients. The main outcome variables were graft and patient survival for up to 20 years, and the time-course of serum creatinine and proteinuria in the first 5 years after transplantation. Cumulative survival rates were estimated by the Kaplan-Meier method and compared using the log-rank test.

RESULTS:

We included 53 patients LN group (n=21) and PCKD group (n=32). Baseline clinical characteristics were similar in both groups, except age at transplantation (39.8±11.3 years in the LN group and 46.6±5.0 years in the PCKD group; p=0.004). No significant differences were found regarding graft (p=0.59) or patient survival (p=0.087) at 20 years of follow-up.

CONCLUSIONS:

Despite concerns about LN recurrence after renal transplantation, this study shows that this procedure might be a safe alternative therapy for ESRD related to SLE and may provide long-term survival.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nefritis Lúpica / Trasplante de Riñón / Fallo Renal Crónico / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Exp Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nefritis Lúpica / Trasplante de Riñón / Fallo Renal Crónico / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Exp Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: España